Atlas Trials

Safety Study of EF-022 in Adults With Recurrent Respiratory Papillomatosis (RRP)

Clinical trial NCT02854761 · UNKNOWN

Trial details

NCT number
NCT02854761
Sponsor
Efranat Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Recurrent Respiratory Papillomatosis
Start date
2016-09-01
Primary completion
2018-09-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.